Notification about latest news from us.
The FDA has approved Journavx, a groundbreaking non-opioid painkiller, marking the first new class in over 20 years, aiming to eliminate the risks of opioid addiction.
J&J has paused the Varipulse heart device rollout in the US amid concerns over reported stroke incidents.
By clicking send you'll receive occasional emails from newsletters about this topic.